With exciting data for immuno-oncology in lung cancer, there is much anticipation for what 2018 holds. In this interview, Solange Peters, MD, PhD, of Lausanne University Hospital, Lausanne, France, updates us on the immunotherapy trial data to look out for in 2018. Prof. Peters also discusses what she hopes the European Society of Medical Oncology (ESMO) 2018 Congress later in the year will have on the agenda in this field. This video was recorded at the British Thoracic Oncology Group (BTOG) Annual Conference 2018, held in Dublin, Ireland.
Lung cancer immunotherapy trial data to look forward to in 2018
